uniQure (Nasdaq: QURE) has been a public company since 2014.

We thank our investors for their support as we advance our gene therapy pipeline toward commercialization.
Contact us at any time.

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease modifying therapies to patients with severe disorders.

We are leveraging our modular and validated technology platform to rapidly advance a focused pipeline of gene therapies.

Stock Quote

Recent News


Upcoming Events:

November 19, 2018 
uniQure R&D Day 2018
08:30 a.m. ET / 14:30 CET
Click here to view webcast

Webcast Archive:

October 2, 2018
Leerink Roundtable Series
3:00 p.m. ET/ 9:00 p.m. CET
Click here to view webcast

October 3, 2018
Cantor Fitzgerald Global Healthcare Conference
9:10 a.m. ET/ 3:10 p.m. CET
Click here to view webcast

September 5 - 6, 2018
Citi 13th Annual Biotech Conference
Thursday, September 6, 2018
10:00 a.m. ET/ 16:00 CET
Click here to view webcast 

September 5 - 6, 2018
Wells Fargo 2018 Healthcare Conference
Wednesday, September 5, 2018
3:35 p.m. ET/ 21:35 CET
Click here to view webcast